Mesa, AZ, United States of America

Garrick Wallstrom

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 27(Granted Patents)


Company Filing History:


Years Active: 2018-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Garrick Wallstrom: Innovator in Cancer Detection

Introduction

Garrick Wallstrom is an accomplished inventor based in Mesa, AZ, recognized for his significant contributions to the field of medical diagnostics. With a total of nine patents to his name, Wallstrom is particularly noted for his innovations aimed at the early detection of various cancers, enhancing the potential for timely interventions and improved patient outcomes.

Latest Patents

Among Wallstrom's latest patents, two notable inventions stand out. The first patent focuses on "Autoantibody biomarkers for the early detection of ovarian cancer," which includes a comprehensive panel of antigen biomarkers. These biomarkers, selected from a specific group including ICAM3, CTAG2, p53, STYXL1, PVR, POMC, NUDT11, TRIM39, UHMK1, KSR1, and NXF3, are coupled to a substrate, providing novel methods for early cancer detection.

The second significant patent is centered around "Plasma autoantibody biomarkers for basal-like breast cancer." This innovation identifies tumor-derived proteins that elicit antibody responses in cancer patients, presenting potential early detection biomarkers. A 13-antibody classifier has been developed, differentiating patients with basal-like breast cancer from healthy controls with 33% sensitivity at 98% specificity.

Career Highlights

Garrick Wallstrom has collaborated with notable institutions, including the Arizona Board of Regents on behalf of Arizona State University and the President and Fellows of Harvard College. His expertise in the field of cancer biomarkers has positioned him as a key player in advancing diagnostic techniques that could save lives.

Collaborations

Wallstrom's research has benefited from collaborations with distinguished colleagues such as Joshua LaBaer and Karen Anderson. These partnerships have enriched his work and contributed to the successful development of his groundbreaking patents.

Conclusion

Garrick Wallstrom exemplifies innovation in the field of cancer detection through his extensive patent portfolio. His dedication to research and collaboration has pioneered new methods for early diagnosis, potentially transforming the landscape of cancer care. As the fight against cancer continues, Wallstrom's contributions are invaluable in advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…